11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Meet Veristat at the Orphan Drug Congress, 14-17 November 2022
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running or just need medical writing or biostatistical support for your programs - Veristat can help. We provide impactful solutions on both a full-service or functional service basis.
Veristat team members Mariska van der Heijden, VP of European Sales and Balma Gil Gimeno, Business Development Director, will be at the venue— ready to listen to your needs and share Veristat’s expertise in orphan drug development.
Schedule A Meeting
If you’d like to talk to us, simply schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to a successful outcome or learn more about our capabilities.
Virtual Conference Details
Website: https://www.terrapinn.com/conference/world-orphan-drug-congress/index.stm
2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...